New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
08:42 EDTMNKDMannKind Afrezza facing 'daunting' commercial hurdles, says JPMorgan
JPMorgan believes Afrezza's label with a Black Box warning and requirement for pulmonary testing show the FDA's concerns around pulmonary toxicity. The firm believes the drug faces "daunting" commercial hurdles and it keeps a Neutral rating on the stock with a $6 price target.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
05:52 EDTMNKDStocks with implied volatility movement; MNKD LOCO
Subscribe for More Information
05:39 EDTMNKDMannKind, Sanofi on track to launch Afrezza in Q1, says Piper Jaffray
Subscribe for More Information
November 12, 2014
05:50 EDTMNKDStocks with implied volatility movement; MNKD XLF
Stocks with implied volatility movement; MannKind (MNKD) 65, Financial Select Sector (XLF) 15 according to iVolatility.
November 11, 2014
16:01 EDTMNKDOptions Update; November 11, 2014
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use